Graham Miles

Professor Maxi Scherer is a special counsel in the firm's Litigation/Controversy Department, and a member of the International Arbitration Practice Group. She has extensive experience with arbitral practice and procedure in civil and common law systems both in commercial and investment arbitration. Regularly ranked by Who’s Who Legal, The Legal 500 etc. as a leading arbitration practitioner, she has been identified amongst the top 20 “Global Elite Thought Leaders” and descri...

David Evans is Chair of Goodwin’s European offices and a partner in Goodwin’s Real Estate Industry group. He is a former member of the firm’s Executive Committee. Mr. Evans' practice focuses on all aspects of real estate fund structuring and formation, as well as joint ventures and mergers and acquisitions in the real estate arena. Mr. Evans has considerable experience dealing with complex tax and real estate issues applicable to fund structuring, for both UK and pan-Europea...

Justin Watts is an experienced patent litigator who has an established and well-regarded intellectual property practice. Clients rely on his industry knowledge and years of experience to handle their complex, multinational disputes. Dr. Watts represents a variety of clients, with an emphasis on those in the pharmaceutical, medical devices, biotechnology, communications, and hardware and software industries, in disputes involving standards, competition law and patents. Dr. Watts' experience en...

Tim is a partner in Goodwin’s Technology and Life Sciences groups, based in the Cambridge and London offices.Mr. Worden regularly advises life sciences companies on licensing and partnering deals, R&D agreements, clinical trials agreements, distribution agreements, and a broad spectrum of regulatory matters. His expertise also includes advising on the IP and regulatory aspects of M&A transactions, IPOs and venture capital investments. Outside of the life sciences sector, Mr. Wor...

When multinational corporations consider major transactions, tax implications often make or break the deal. Charlotte Sallabank advises on those implications, advising clients on the direct and indirect tax consequences of their largest business decisions. Her creativity, persuasive power and close attention to her clients' business aspirations consistently result in solutions that make them a reality.A complete perspective on tax-planning issuesWith more than 30 years of experience advising ...

James Fisher is a partner in the Finance Group in Alston & Bird’s London office, focusing on debt capital markets, structured finance, securitisation, and derivatives transactions, with a particular specialty in advising corporate trust, agency, and issuer clients across a broad spectrum of cross-border and domestic financings.

Mr. Macaulay has been recommended as a leading individual for over a decade in both Chambers UK and The Legal 500 UK. He has been described in these publications as an “unflappable” lawyer who “has extremely good judgement and is a ruthless tactician;” and is “rock solid;” “tenacious;” “a financial disputes expert;” and a “seasoned litigator.” He was included in Who’s Who Legal: Arbitration 2021’s annual Globa...

Sharon Lamb focuses her practice on transactional and regulatory advice in the health and life sciences sector. Sharon advises on global transactional mandates, including mergers and acquisitions and joint ventures in health services, pharma and life sciences, digital health and health data technologies. Sharon also provides strategic, regulatory and commercial support to UK and international clients on UK health and life sciences with a focus on health services, pharmaceuticals, medical devi...

Wim De Vlieger is a partner in the London office of Gibson, Dunn & Crutcher. Mr. De Vlieger is Co-Head of Private Equity in Europe and a member of the Mergers and Acquisitions and Capital Markets practice groups. Mr. De Vlieger advises private equity investors and their portfolio companies on a wide range of corporate transactions, including growth equity and control investments and co-investments, structured transactions, buy-out transactions, mergers and acquisitions, and exits. He also...

Gary Born is the chair of the International Arbitration Practice Group. Mr. Born is widely regarded as the world's preeminent authority on international commercial arbitration and international litigation. He has been ranked for more than 20 years as one of the world's leading international arbitration advocates and the leading arbitration practitioner in London.